Abstract
Background/Aim: Endometriosis is a benign condition affecting 10-20% of women at reproductive age. The urinary tract is affected in 0.3-12.0% of women with endometriosis and in 19.0-53.0% of women with deep infiltrating endometriosis. The bladder is the most commonly affected organ in the urinary tract with a prevalence of up to 80%. Bladder endometriosis is defined as the occurrence of endometrial glands and stroma in the detrusor muscle. The aim of the study was to present the detailed technique and intraoperative and postoperative outcomes of laparoscopic resection of bladder endometriosis. Patients and Methods: This was a retrospective study analyzing all surgical procedures, carried out at the Academic Hospital Cologne Weyertal between January 2014 and December 2022. In total 23,862 surgical reports were analyzed, and only patients (n=33 patients) with bladder endometriosis were included in the study. Results: Follow-up was performed in 25 patients by phone contact. Twenty-three patients (92%) reported an improvement of symptoms, especially of dysuria, and an increase of quality of life. Only two patients (8%) reported no change in symptoms (dysmenorrhea and dyspareunia). Two patients (8%) reported bladder dysfunction. Mild postoperative pollakiuria was reported by two patients (8%). Four patients (with mild bladder dysfunction and pollakiuria) were satisfied with postoperative results owing significant improvement of symptoms and increasing the quality of life. Conclusion: Surgical treatment of bladder endometriosis can be performed by a gynecologist. In cases where a ureteroneocystostomy is required or the localization of endometriosis nodule is unfavorable, an intervention by a multidisciplinary team is recommended. Laparoscopic partial cystectomy and shaving seem to be an appropriate method for improving urinary symptoms. This surgical approach requires excellent laparoscopic skills.
Endometriosis is a common benign condition that affects 10-20% of women of reproductive age (1). There are three main forms of endometriosis: superficial peritoneal endometriosis, ovarian endometriosis and deep infiltrating endometriosis (DIE) (2). DIE is defined as infiltration of endometriotic lesions into the peritoneum >5 mm (3). DIE occurs in 1% of women of reproductive age and is the most severe form (2). The urinary tract is one of the most common extragenital organ systems affected by endometriosis. The prevalence ranges from 0.3-12% in all women affected by endometriosis and 19-53% in women with DIE (4-6). The bladder is the most commonly affected organ in the urinary tract with a prevalence of up to 80% of cases, followed by ureteral involvement with an occurrence of 9-23% (4, 7). Bladder endometriosis is defined as the occurrence of endometrial glands and stroma in the detrusor muscle. The most frequently affected parts of the bladder are the base and the dome (8). However, in the majority of cases, the mucosa of bladder is not affected (9). There are two theories regarding the origin of bladder endometriosis: primary or spontaneous development and secondary development. The primary development includes two theories: 1) implantation of endometrial cells due to retrograde menstruation and development of adhesions; 2) metaplasia of adenomyosis. The secondary theory explains the development of bladder endometriosis due to bladder injury after pelvic surgery (e.g., caesarean section, hysterectomy etc.) and following a contamination of endometrial cells (8). The symptoms caused by bladder endometriosis include suprapubic pain accompanied by polyuria (41%), dysuria (21%), hematuria (19%), as well as repeated urinary tract infections (10). Bladder endometriosis is classified by the ENZIAN/#ENZIAN classification as “FB” (11). For the treatment of bladder endometriosis, several options, such as a hormonal therapy and surgery [laparoscopic/laparotomic partial bladder resection, “shaving” and transurethral resection (TUR)] are suggested (12). The aim of the study was to present the intraoperative and postoperative outcomes of laparoscopic management for bladder endometriosis.
Patients and Methods
This was a retrospective study that analyzed all surgeries, that were carried out at the Academic Hospital Cologne Weyertal between January 2014 and December 2022. Academic Hospital Cologne Weyertal is a level III endometriosis Center where 750-1,000 laparoscopic endometriosis surgeries are performed annually. In total 23,862 surgical reports were analyzed. In this study only patients (n=33) with bladder endometriosis were included. Preoperative assessment was performed by vaginal sonography. To assess the bladder mucosa, as well as the distance between the endometriosis nodule and the ureteral orifices, a cystoscopy was performed in all cases. Histological confirmation of the resected endometriosis nodules was mandatory. It was investigated in which cases a urological intervention was necessary. The surgical approach was divided into shaving and partial cystectomy. The follow-up was performed by phone contact. The patients were asked regarding improvement of symptoms, postoperative bladder dysfunction, as well as reintervention. The size of endometriosis nodule was evaluated using the histological examination report. To classify peritoneal and ovarian endometriosis, the rASRM classification was used, and ENZIAN was used to classify DIE lesions.
Procedure. All surgeries were performed by experienced certificated laparoscopic surgeons [minimal invasive surgery (MIS) level II and III, certificated by the German society for gynecological endoscopy]. We divided the bladder endometriosis surgical procedure into sequential steps. The first step was the cystoscopy for evaluating the mucosa and ureteral orifices (Figure 1A and B). The second step was laparoscopic visualization. During the laparoscopy adenomyosis, adhesions and endometriosis in other localization were evaluated (Figure 2A and B). Step three: Complete adhesiolysis in case of any adhesions between the bladder and the uterus, as well as round ligament of the uterus, which enables a sufficient resection of endometriosis nodule.
The fourth step was resection of the endometriosis nodule. For this reason, either partial cystectomy or shaving can be used (Figure 3A and B). We defined shaving as the resection of the bladder layer without involvement of mucosa.
After successful endometriosis resection, the distance between ureters/ureteral orifices and the resection edge should be evaluated (Figure 4): step five. The final step, step six, was the suture (Figure 5). Postoperatively all patients retained a bladder catheter for 10 days.
Results
Patient characteristics. Thirty-three patients with bladder endometriosis, who underwent a laparoscopy, were included in this retrospective analysis. The age ranged from 25 to 48 years. All patients were symptomatic. The majority of patients had symptoms, such as dysmenorrhea and dysuria. Dyschezia and dyspareunia were less common. Only two patients had hematuria. Twelve patients had symptoms despite hormonal therapy. 23 patients had previous surgery, whereby 16 patients had one surgery and seven patients ≥2 surgeries. The main patient characteristics are presented in Table I.
Intraoperative outcomes. A cystoscopy for evaluating affected mucosa and the distance between the endometriosis nodule and “golden triangle” was performed. In the majority of cases, the endometriosis nodule bulged into or infiltrated the mucosa. The size of the endometriosis nodule ranged from 1 to 4.5 cm and was verified according to histopathological reports. The majority of patients had a nodule of 2-4 cm. Adenomyosis, adhesions and other endometriosis locations were determined by laparoscopy. The resection of bladder endometriosis took place in thirty cases. In 3 cases, patients did not require bladder surgery. However, these three cases were included, in order to evaluate other statistical data (symptoms, adhesions, other endometriosis etc.). Partial cystectomy was the procedure most commonly used in contrast to “shaving”, which was performed only in a few cases. A urologist involvement was necessary in three cases, whereby in two cases a ureteroneocystostomy was performed. For the bladder suture Vicryl, V-Loc as well as polydioxanone suture (PDS) thread were used. The main intraoperative outcomes are presented in Table II and Figure 6.
Postoperative outcomes. In three out of 23 cases after partial cystectomy, postoperative bleeding occurred. Two of the patients had a 4-cm nodule and one patient a 2-cm nodule. In two cases a re-laparoscopy was necessary and in one case the bleeding stopped spontaneously. One patient had ureteral stenosis after partial cystectomy with a 3.5 cm endometriosis nodule, therefore a urological reintervention was necessary. No complications after shaving were observed.
Follow-up was performed in 25 patients by phone contact. Twenty-three patients (92%) reported an improvement of symptoms, especially of dysuria, and increase of quality of life. Only two patients (8%) reported no change in symptoms (dysmenorrhea and dyspareunia). Two patients (8%) reported bladder dysfunction. However, in one case, the patient reported mild bladder dysfunction and it did not affect her quality of life. In another case, the patient had had the bladder dysfunction already before the surgery and it did not increase after surgery. Mild postoperative pollakiuria was reported by two patients (8%). Four patients (with mild bladder dysfunction and pollakiuria) were satisfied with postoperative results owing significant improvement of symptoms and increasing the quality of life. No patient underwent reintervention because of endometriosis recurrence until follow-up.
Discussion
Bladder endometriosis is a rare condition, but it should be taken into account in patients with bladder symptoms and in the absence of urine infection (10). There are certain theories about the origin of bladder endometriosis. Some authors attribute the origin to retrograde menstrual bleeding and implantation of endometrial cells on the bladder peritoneum. After implantation, the inflammatory process facilitates the development of adhesions between the bladder and the uterus, and the formation of a fibrotic nodule, apparently of the vesicovaginal septum, that is buried under the peritoneum (10, 13). Another theory is that the lesions are an extension of adenomyotic lesions arising from the myometrium (14, 15). The occurrence of adenomyosis, and adhesions between the bladder and uterus, in our case series, confirm these theories (Table II).
Bladder endometriosis can be treated both with hormonal therapy and surgery. For medical therapy, combined hormonal contraceptives and progestogens should be regarded as first-line therapy (16-18). However, it has been reported, that the bladder endometriosis nodule itself and associated symptoms may respond suboptimally to hormone therapy (19). The data of our case series are in line with this conclusion (Table I). Furthermore, the medical therapy is effective in temporarily suppressing, but not curing of bladder endometriosis. If hormone therapy is chosen, patients should be informed about long-term treatment and that bladder endometriosis may progress under therapy, so a regular control is advisable (12, 17). For this reason, surgery may be required. For surgery, an accurate diagnosis using ultrasound and cystoscopy is mandatory. Depending on the size and location, an interdisciplinary procedure with a urologist may be required. The goal should be complete resection of the endometriosis nodule, which on the one hand facilitates significant improvements in pain and urinary symptoms and on the other minimizes the recurrence risk (20-25). Certain techniques are suggested for surgical treatment: transurethral resection (TUR), partial resection, as well as shaving (12, 26). However, there exist concerns about TUR. A complete resection with TUR is unachievable, since the nodule develops from the outer layer towards to the inner layer of the bladder wall. Furthermore, the data of this study show that an endometriosis nodule is not always detectable with cystoscopy (Table II). TUR has a high risk of bladder perforation and a recurrence of endometriosis (25, 27-29). For this reason, TUR cannot be considered as an efficient treatment of bladder endometriosis (12). In contrast, many authors reported that a partial cystectomy is an effective method with excellent long-term results in terms of symptom relief and recurrence (12).
In our case series, partial cystectomy was performed in 23 cases. The average nodule size was 2.5 cm. Many authors stated that partial cystectomy can be performed by a gynecologist if the distance between the endometriosis nodule and ureteral orifices is at least 2 cm (30). The authors of this study agree with this statement. In our study, in three cases the involvement of a urologist was necessary. However, in two cases, patients had ureter obliteration caused by endometriosis and a ureteroneocystostomy was planned. In one case, the distance between nodule and ureteral orifices was less than 2cm.
Inserting D-J stents is optional for primary surgery of bladder endometriosis (12). We could not find any publication, showing an advantage of D-J stents in surgery of DIE. However, two studies reported no difference in terms of ureter injury in patients with and without D-J stents, who had undergone surgery for DIE. The risk of bladder infection, on other hand, is significantly higher in patients with D-J stents (31, 32).
Rich bladder vascularization and sterile content enable a good healing process after partial cystectomy. Another important point, which should be taken into account, is prolonged urine drainage (~10 d) (33). However, rich bladder vascularization can increase the risk of bleeding. Three out of 30 patients in our case series had postoperative bleeding. In two cases, a re-laparoscopy was necessary. In one case, the bleeding stopped spontaneously, and a bladder tamponade was treated using an irrigation catheter.
Shaving is defined as an extramucosal dissection of the bladder wall. Many authors reported good results after shaving in terms of improvement of symptoms and safety of the method (9, 34-36). In our case series, seven patients underwent shaving. In all cases the cystoscopy showed no mucosa infiltration. In three cases bladder suture after deep shaving was carried out, in order to prevent a fistula. There were neither intraoperative, nor postoperative complications.
In our case series, only resorbable thread was used (Table II). In 55% of cases polyglactin thread, in 15% barbed and in 9% PDS was used for bladder suture. No difference in suture time, postoperative complication in terms of bleeding and bladder dysfunction, as well as improvement of symptoms were observed in our analysis. The above thread materials have been used/suggested by several authors (26, 37). Follow-up revealed improvement of symptoms in 92% of cases.
The risk of endometriosis-associated malignancies of the urinary tract is very low. Only a few cases of endometriosis-associated malignancies in the urinary tract have been reported in the literature, and most of these involved the bladder (38).
Conclusion
This analysis showed that surgical treatment of bladder endometriosis can be performed by a gynecologist. In cases where a ureteroneocystostomy is required or the localization of endometriosis nodule is unfavorable, an intervention by multidisciplinary team, including a gynecologist and a urologist, is recommended. Laparoscopic partial cystectomy and shaving seem to be an appropriate method for improving urinary symptoms, with a low rate of intra- and postoperative complications even in patients with large endometriosis nodules. However, such complications as bleeding, pollakiuria, bladder dysfunction as well as incomplete healing of the bladder or suture leakage can occur and should be taken into account. This surgical approach requires excellent laparoscopic skills.
Footnotes
Authors’ Contributions
EP: Manuscript writing, data management, data analysis. SS and TR: project development and administration.
Conflicts of Interest
The Authors have no conflicts of interest regarding this study.
- Received November 30, 2022.
- Revision received December 10, 2022.
- Accepted December 16, 2022.
- Copyright © 2023, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY-NC-ND) 4.0 international license (https://creativecommons.org/licenses/by-nc-nd/4.0).